Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain Management
HRQoL and pain intensity significantly improved after PGx testing, with potentially clinically relevant results in the PGx-guided therapy group. Due to the observational nature of the study, further controlled studies are required to assess the clinical impact and economic feasibility of PGx-guided therapy.
Authors
- Kurt E. Hersberger (ORCID: https://orcid.org/0000-0001-8678-697X)
- Nikki Rommers (ORCID: https://orcid.org/0000-0003-0311-5009)
- Samuel Allemann (ORCID: https://orcid.org/0000-0003-4067-9401)
- Anna Bollinger (ORCID: https://orcid.org/0000-0003-4616-2534)
- Matthias Schwenkglenks (ORCID: https://orcid.org/0000-0001-7217-1173)
- Henriette E. Meyer zu Schwabedissen (ORCID: https://orcid.org/0000-0003-0458-4579)
- Céline K. Stäuble (ORCID: https://orcid.org/0000-0002-2437-4803)
- Julia Gianora
- Isabelle O. Urdieux
Institutions
- University of Basel (CH)
- University Hospital of Basel (CH)
- Stadtspital Waid (CH)
Publication Details
- Journal
- Health Services Insights
- Published
- 2025-07-12
- DOI
- https://doi.org/10.1177/11786329251356560
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00